Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon) (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
acyclovir 250 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
amphotéricine 50 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
acyclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
clarithromycine 500 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amifostine 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amifostine 375 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
topotecan 4mg powder for infusion solution vial (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
vancomycine 500 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
érythromycine 1g, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
vancomycine 1 g, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely oxaliplatin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
gemcitabine 200mg powder for infusion solution vial (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
quinupristine 150 mg et dalfopristine 350 mg, fiole de poudre pour perfusion |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Imiglucerase 400 unit powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Raltitrexed 2 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Verteporfin 15 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Glatiramer acetate 20 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ticarcilline 3 g/acide clavulanique 200 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Trastuzumab 150 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ganciclovir 500 mg, fiole de poudre pour perfusion (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Infliximab 100 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Imiglucerase 200 unit powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|